Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Addus HomeCare Corporation - Common Stock (NQ:ADUS)

109.27 -1.00 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Addus HomeCare Corporation - Common Stock

< Previous 1 2 3 4 Next >
3 Profitable Stocks with Open Questions
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
3 Cash-Producing Stocks We Steer Clear Of
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Addus HomeCare Corp (NASDAQ:ADUS) Screened as a High-Quality Stock by Caviar Cruise Strategy
Addus HomeCare (ADUS) is a high-quality growth stock with strong profitability, exceptional cash flow, and a solid balance sheet, making it a top pick for long-term investors. 
Via Chartmill
Forecasting The Future: 5 Analyst Projections For Addus HomeCare
 
Via Benzinga
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Lawsuit
ADUS Q2 Deep Dive: Personal Care Expansion and State Reimbursement Bolster Growth
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 21.8% year on year to $349.4 million. Its non-GAAP profit of $1.49... 
Via StockStory
Addus HomeCare (ADUS) Q2 Revenue Up 22%
Via The Motley Fool
Addus HomeCare (NASDAQ:ADUS) Surprises With Q2 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 21.8% year on year to $349.4 million. Its non-GAAP profit of... 
Via StockStory
Earnings Scheduled For August 4, 2025
 
Via Benzinga
Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
Earnings Scheduled For May 5, 2025
 
Via Benzinga
2 of Wall Street’s Favorite Stocks to Keep an Eye On and 1 We Question
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
3 Healthcare Stocks That Concern Us
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Assessing Addus HomeCare: Insights From 5 Financial Analysts
 
Via Benzinga
3 Low-Volatility Stocks in Hot Water
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Home Health Braces For Potential $1 Billion Cut In Medicare Payments
The Centers for Medicare & Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pays home health agencies (HHAs) in calendar year (CY) 2026. These updates are... 
Via Benzinga
Senior Health, Home Health & Hospice Stocks Q1 Results: Benchmarking Addus HomeCare (NASDAQ:ADUS)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how senior health, home health & hospice stocks fared in Q1,... 
Via StockStory
Topics Economy
Demystifying Addus HomeCare: Insights From 4 Analyst Reviews
 
Via Benzinga
3 Small-Cap Stocks in Hot Water
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
3 Cash-Producing Stocks with Mounting Challenges
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
1 Profitable Stock on Our Buy List and 2 to Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
ADUS Q1 Earnings Call: Personal Care Drives Growth as Addus HomeCare Looks to Expand
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its non-GAAP profit of $1.42 per share... 
Via StockStory
Breaking Down Addus HomeCare: 6 Analysts Share Their Views
 
Via Benzinga
Addus HomeCare (NASDAQ:ADUS) Misses Q1 Revenue Estimates
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its non-GAAP profit of $1.42 per share... 
Via StockStory
Why ADDUS HOMECARE CORP (NASDAQ:ADUS) qualifies as a quality stock.
A fundamental analysis of (NASDAQ:ADUS): Is NASDAQ:ADUS a Suitable Choice for Quality Investing? 
Via Chartmill
Addus HomeCare (ADUS) Reports Earnings Tomorrow: What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Q4 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its... 
Via StockStory
Topics Economy
1 Healthcare Stock for Long-Term Investors and 2 to Keep Off Your Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Senior Health, Home Health & Hospice Stocks Q4 Recap: Benchmarking The Pennant Group (NASDAQ:PNTG)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at The Pennant Group (NASDAQ:PNTG) and its peers. 
Via StockStory
Topics Economy
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.